Descriptor English: | Complement C5a, des-Arginine | ||||
Descriptor Spanish: |
Complemento C5a des-Arginina
| ||||
Descriptor Portuguese: | Complemento C5a des-Arginina | ||||
Descriptor French: | Complément C5a des-Arg | ||||
Entry term(s): |
C5 a, des Arg C5 a, des Arginine C5 a, des-Arg C5 a, des-Arginine C5a des Arginine C5a des-Arg C5a des-Arginine C5a, des Arg C5a, des Arginine C5a, des-Arg C5a, des-Arginine C5a, des-Arginine Complement Complement 5a, de Arginine Complement 5a, de-Arginine Complement 5a, des Arginine Complement 5a, des-Arginine Complement C5a, des Arginine de-Arginine Complement 5a des-Arg C5 a des-Arg C5a des-Arg, C5a des-Arginine C5 a des-Arginine C5a des-Arginine Complement 5a des-Arginine Complement C5a des-Arginine, C5a |
||||
Tree number(s): |
D12.776.124.486.274.024.270.255 D12.776.124.486.274.450.250.255 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D015937 | ||||
Scope note: | A derivative of complement C5a, generated when the carboxy-terminal ARGININE is removed by CARBOXYPEPTIDASE B present in normal human serum. C5a des-Arg shows complete loss of spasmogenic activity though it retains some chemotactic ability (CHEMOATTRACTANTS). |
||||
Allowable Qualifiers: |
AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||
Pharm Action: |
Immunologic Factors |
||||
Previous Indexing: |
Complement 5 (1979-1989) |
||||
Public MeSH Note: | 2006; see COMPLEMENT 5A, DES-ARGININE 1990-2005 |
||||
History Note: | 2006 (1990) |
||||
Entry Version: | C5A DES ARG |
||||
DeCS ID: | 24581 | ||||
Unique ID: | D015937 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 1990/01/01 | ||||
Date of Entry: | 1989/07/14 | ||||
Revision Date: | 2005/06/30 |
-
-
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins
|
Complement C5a, des-Arginine
- Preferred
Concept UI |
M0024382 |
Scope note | A derivative of complement C5a, generated when the carboxy-terminal ARGININE is removed by CARBOXYPEPTIDASE B present in normal human serum. C5a des-Arg shows complete loss of spasmogenic activity though it retains some chemotactic ability (CHEMOATTRACTANTS). |
Preferred term | Complement C5a, des-Arginine |
Entry term(s) |
C5 a, des Arg C5 a, des Arginine C5 a, des-Arg C5 a, des-Arginine C5a des Arginine C5a des-Arg C5a des-Arginine C5a, des Arg C5a, des Arginine C5a, des-Arg C5a, des-Arginine C5a, des-Arginine Complement Complement 5a, de Arginine Complement 5a, de-Arginine Complement 5a, des Arginine Complement 5a, des-Arginine Complement C5a, des Arginine de-Arginine Complement 5a des-Arg C5 a des-Arg C5a des-Arg, C5a des-Arginine C5 a des-Arginine C5a des-Arginine Complement 5a des-Arginine Complement C5a des-Arginine, C5a |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey